KROS: Keros Therapeutics Inc
KROS exchange rate has changed by -3.00% for today. During the day, the instrument was traded at a low of 11.2500 and at a high of 11.5750.
Follow Keros Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KROS News
- KROS 2026 Watchlist: 3 Catalysts That Could Reset Sentiment
- KROS Stock: Does the Takeda Deal Lower Dilution Risk in 2026?
- KROS Rinvatercept: What to Know Before DMD Phase II Starts
- Why Is Keros Therapeutics (KROS) Up 2.5% Since Last Earnings Report?
- Insmed (INSM) Soars 5.5%: Is Further Upside Left in the Stock?
- KROS Pipeline Catalysts: DMD Phase II and ALS Plans for 2026
- KROS Stock: What to Know About Rinvatercept in DMD
- KROS: Is the Discount Book Value a Value Trap?
- Can Keros Therapeutics Rinvatercept Stand Out in the DMD Market?
- Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?
- Keros Therapeutics, Inc. (KROS) Reports Q4 Loss, Misses Revenue Estimates
- Keros earnings missed by $0.16, revenue fell short of estimates
- Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings?
- Will Reblozyl Shine in Bristol Myers' Fourth-Quarter Results?
- SRPT Stock Up 8% on Positive Long-Term Data From Elevidys Study in DMD
- Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside?
- Is KROS' KER-065 the Next Breakthrough in DMD Space?
- JANX Enters Global Oncology Collaboration With BMY, Stock Rises
- Ionis' Dawnzera Gets EU Approval for Hereditary Angioedema
- MRKR Stock Up Nearly 114% in 3 Months: Here's What You Need to Know
- Novartis' Ianalumab Wins Breakthrough Therapy Tag for Sjogren's Disease
- Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia
- Will KROS Stock's Restructuring Efforts Reap Rewards for Investors?
- CG Oncology Stock Rallies Nearly 32% in a Week: Here is Why
Frequently Asked Questions
What is KROS stock price today?
Keros Therapeutics Inc stock is priced at 11.3100 today. It trades within 11.2500 - 11.5750, yesterday's close was 11.6600, and trading volume reached 558. The live price chart of KROS shows these updates.
Does Keros Therapeutics Inc stock pay dividends?
Keros Therapeutics Inc is currently valued at 11.3100. Dividend policy depends on the company, while investors also watch -25.10% and USD. View the chart live to track KROS movements.
How to buy KROS stock?
You can buy Keros Therapeutics Inc shares at the current price of 11.3100. Orders are usually placed near 11.3100 or 11.3130, while 558 and -2.08% show market activity. Follow KROS updates on the live chart today.
How to invest into KROS stock?
Investing in Keros Therapeutics Inc involves considering the yearly range 10.4150 - 22.5500 and current price 11.3100. Many compare 2.08% and -24.95% before placing orders at 11.3100 or 11.3130. Explore the KROS price chart live with daily changes.
What are Keros Therapeutics Inc stock highest prices?
The highest price of Keros Therapeutics Inc in the past year was 22.5500. Within 10.4150 - 22.5500, the stock fluctuated notably, and comparing with 11.6600 helps spot resistance levels. Track Keros Therapeutics Inc performance using the live chart.
What are Keros Therapeutics Inc stock lowest prices?
The lowest price of Keros Therapeutics Inc (KROS) over the year was 10.4150. Comparing it with the current 11.3100 and 10.4150 - 22.5500 shows potential long-term entry points. Watch KROS moves on the chart live for more details.
When did KROS stock split?
Keros Therapeutics Inc has gone through stock splits historically. These changes are visible in , 11.6600, and -25.10% after corporate actions.
- Previous Close
- 11.6600
- Open
- 11.5500
- Bid
- 11.3100
- Ask
- 11.3130
- Low
- 11.2500
- High
- 11.5750
- Volume
- 558
- Daily Change
- -3.00%
- Month Change
- 2.08%
- 6 Months Change
- -24.95%
- Year Change
- -25.10%
- Act
- Fcst
- 0.705 M
- Prev
- -0.913 M
- Act
- Fcst
- 0.076 M
- Prev
- -1.727 M
- Act
- Fcst
- Prev
- 4.817%